Merck

Healthcare

Merck Takes on Brain Cancer With Acquisition of Yale Spinoff Modifi

Photo by JHVEPhoto via iStock

Modifi Biosciences announced that it has been acquired by global pharmaceutical giant Merck, with a $30 million down payment.

1 min read

Photo by Anastasia Nelen via Unsplash

Healthcare

Pfizer on Opposite Sides of Two Promising Vaccine Trials

Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.

1 min read
Photo by Polina Tankilevitch via Pexels

Healthcare

Moderna Inches Nearer to Successful Cancer Vaccine

The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.

1 min read
(Photo by Towfiqu Barbhuiya on Unsplash)

Healthcare

Pharma Giants Combine Forces to Fight New M&A Rules

Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.

2 min read

Healthcare

Merck Staring Down Patent Cliff of Its Lucrative Cancer Wonder Drug

Photo Credit: Adobe.com.

1 min read

Photo by Kārlis Dambrāns via CC BY-SA 4.0

International Economics

China Brings in Subsidies for Smartphones

On Friday, Beijing announced that a trade-in program that previously applied to big appliances and cars will now be widened to smartphones.

1 min read
Photo by David Vives via Unsplash

Private Equity

Will Private Equity Fuel a Big Year for IPOs?

As the New Year rolls in, Wall Street is preparing for a slew of listing announcements from private equity-backed firms.

2 min read
Photo illustration by Connor Lin / The Daily Upside, Photo by Rawpixel via Freepik

Private Equity

All in the Franchise: Why Private Equity Loves the Business Model

It’s understandable if you failed to notice one meaty if unglamorous trend on Wall Street: Private equity’s love affair with franchising.

6 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.